Product
Dendritic Cell/Tumor Fusion Vaccine
1 clinical trial
3 indications
Indication
Ovarian CancerIndication
Primary Peritoneal CancerIndication
Fallopian tube cancerClinical trial
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With GM-CSF and ImiquimodStatus: Active (not recruiting), Estimated PCD: 2024-12-01